TY  - ADVS
AU  - Field,Hugh J.
TI  - Herpes simplex virus and varicella-zoster virus Helicase-Primase inhibitors
T2  - Antivirals : latest developments and future progress,
PY  - 2011///
CY  - London
PB  - Henry Stewart Talks
KW  - Antiviral agents.
KW  - Herpes simplex virus
KW  - Effect of drugs on.
KW  - Herpesvirus diseases.
KW  - Antiviral Agents
KW  - pharmacology.
KW  - DNA Helicases
KW  - antagonists & inhibitors.
KW  - DNA Primase
KW  - Herpes Simplex
KW  - drug effects
KW  - Herpesvirus 3, Human
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Herpesvirus infections in man -- Diseases caused by alphaherpesvirus, HSV and VZV -- Immunocompromised hosts -- Infection, latency and reactivation -- Morphology of herpesvirus virion -- Productive replication cycle -- The herpesvirus genome -- HSV and VZV antiviral therapy -- Nucleoside analogue therapy -- Historical prospective -- Genes coding for proteins targeted by antivirals -- Inhibitors of DNA synthesis -- A new target -- HSV helicase-primase complex -- Clinical potential of Helicase primase inhibitors (HPIs) -- Studying HPI in vivo -- Antiviral efficacy -- Dose response -- The effects of HPI on HSV latency -- The development of HPI antiviral drug resistance -- HPI resistant mutants growth and pathogenicity; Access restricted to subscribers
UR  - https://hstalks.com/bs/2074/
UR  - https://hstalks.com/bs/p/613/
ER  -